Z-0464-2022 Class II Terminated
FDA device recall Z-0464-2022 was initiated by Medtronic Inc., Cardiac Rhythm And Heart Failure (CRHF) on Nov 19, 2021 and is designated Class II. Reason for recall: There have been reports of stent migration. The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 21,653 devices.
Recall details
- Product Type
- Devices
- Report Date
- Jan 12, 2022
- Initiation Date
- Nov 19, 2021
- Termination Date
- Aug 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21,653 devices
Product description
Reason for recall
Distribution pattern
Distribution was nationwide. There was also military/government distribution. Foreign distribution was made to Argentina, Australia, Austria, Bahrain, Belgium, Botswana, Bulgaria, Canary Islands, Chile, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Guatemala, Hong Kong, India, Ireland, Israel, Italy, Jordan, Kenya, Lithuania, Malaysia, Republic of Moldova, Netherlands, New Zealand, Nicaragua, Norway, Oman, Peru, Poland, Portugal, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, and Viet Nam,
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0464-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026